LRRTM1 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

LRRTM1 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 17 amino acid peptide near the carboxy terminus of human LRRTM1.

  Source: Synthetic

  (Accession #: AAH45113)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: LRRTM1
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76528.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for LRRTM1 Antibody Blocking Peptide

• FLJ32082
• leucine rich repeat transmembrane neuronal 1
• leucine-rich repeat transmembrane neuronal 1 protein
• leucine-rich repeat transmembrane neuronal protein 1
• LRRTM1

Background

LRRTM1 may play a role during the development of specific forebrain structures by influencing neuronaldifferentiation and connectivity, with a possible role in intracellular trafficking within axons

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: LRRTM1